Share Price:

APNASPENAspen Pharmacare Hldgs10752-189 (-1.73%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Aspen manufactures Africa’s first generic ARVs

Pretoria – Aspen Pharmacare, Southern Africa’s largest generics manufacturer and JSE Securities Exchange listed pharmaceutical company, has announced the launch of Aspen-Stavudine – the first generic antiretroviral (ARV) drug developed and manufactured in Africa. Stephen Saad, Aspen Pharmacare Group Chief Executive Officer said β€œAspen-Stavudine is the first locally developed and manufactured generic ARV which presents… Continue reading Aspen manufactures Africa’s first generic ARVs

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: